bonescreen

Evidenzbasierte KI: Bayern investiert in Bonescreen und das TUM Universitätsklinikum! Das gemeinsame Projekt, geleitet von bonescreen in Zusammenarbeit mit den Abteilungen für Neurochirurgie und Neuroradiologie des TUM Universitätsklinikum Klinikum rechts der Isar, hat für die kommenden Jahre eine Förderung des Bayerischen Staatsministeriums (via Bayern Innovativ GmbH) erhalten, einer Schlüsselinitiative des Freistaats Bayern. In Zusammenarbeit mit Experten des TUM Universitätsklinikums soll das opportunistische Screening am Universitätsklinikum erweitert werden, um den behandelnden Ärztinnen und Ärzten quantitative Daten zur Knochengesundheit in Echtzeit bereitzustellen. Ein Ziel des Projekts ist es, mit den KI-Lösungen von Bonescreen eine verbesserte und personalisierte OP-Planung zu ermöglichen. „Wir wollen gemeinsam insbesondere dazu beitragen, postoperative Komplikationen zu reduzieren und die individuelle Patientenversorgung zu verbessern“, sagt Priv.-Doz. Dr. Arthur Wagner, leitender Oberarzt der Neurochirurgie und Projektleiter auf neurochirurgischer Seite. Die Investition Bayerns unterstreicht auch das öffentliche Interesse an diesem Projekt: präventive und reproduzierbare KI-Diagnostik birgt das Potenzial für langfristige Kosteneinsparungen im Gesundheitswesen und eine verbesserte Patientenversorgung. Wir freuen uns sehr auf die Zusammenarbeit! Dr. Markus Söder Future of Health Grant EIT Health International Osteoporosis Foundation TUM Venture Labs

What about the EU AI Act? Have you ever  been in the middle of a conversation and thought to yourself,  “Why are we not recording this?!” That happened to me with Anjany from bonescreen who was on a panel yesterday at LSI discussing the European AI Act. Not being a true software guy, this is my translation… The  EU AI Act primarily imposes new regulatory requirements for companies utilizing artificial intelligence in their products, especially in high-risk sectors like healthcare. MedTech companies that are already familiar with EUMDR will likely face additional checks and compliance measures specifically for the AI components of their devices, like algorithm transparency, bias prevention, and continuous performance monitoring to ensure patient safety. For companies already embedded in the regulated healthcare ecosystem, however, the incremental burden might be modest compared to industries that are newer to regulation. So, in that case, the focus is more along the lines of adapting existing compliance processes (audits, traceability, & documentation) to integrate AI-specific questions. If you’re an AI company, I’m curious what kind of impact you’ve felt from the AI Act – let me know! P.S. If you were having Medtech conversations in a monastery, you’d record every conversation too! 😂 #ai #medicaldevices #lsieurope24 #greenlightguru

We are thrilled and honoured to be one of the 8 startups selected from over 200 applicants to join the Future of Health Grant 2024 cohort at Level 2! 🙌 Under expert mentorship, we are eager to collaborate with health service providers and insurance companies to enhance patient access to preventive bone health screenings in Switzerland. A big thank you to EPFL Innovation Park, CSS, and all the FoHG partners – we look forward to a productive journey together! 🚀

The European Union’s AI Act represents one of the most comprehensive regulatory frameworks for artificial intelligence to date. But what does this mean for startups, innovation, and investment in the Medtech sector? In our upcoming #LSIEurope24 panel, "The EU AI Act: Implications for Startups, Innovation, and Investment," we’ll delve into the potential impacts of this legislation on the Medtech ecosystem. Our panelists will discuss how startups can navigate the new regulatory landscape, what the Act means for innovation, and how it might influence investment decisions moving forward. Featured Panelists: • Sophie Ehrlich (Moderator) — EIT Health • Anjany Sekuboyina — bonescreen • Andreu M. Climent — Corify • Andreas Schriefl — eMurmur • Jordina Arcal Cunillera — mjn-neuro Join us at LSI Europe ‘24 this September 16-20th to see more panel sessions like this and connect with hundreds of global Medtech and Healthtech leaders in Sintra, Portugal. Apply on our website today while space is still available.

If you want to learn more about how we are transforming bone disease diagnosis, listen to one of our co-founders sharing some insights on X Ray Tech's Skeleton Crew podcast. https://lnkd.in/dDi56kPV

Do you want to transform diagnostics and preventive care with evidence-based AI? 🏥 Join Bonescreen as a (Senior) Machine Learning Engineer in beautiful Munich 🚀 👩💻 🥨 🌞 🏔 👉 https://lnkd.in/dV3fEUzY and send your CV to career@bonescreen.de Or, if you know someone who knows someone who knows someone... 🤗

This World Osteoporosis Day, marked on October 20th, we’ll be spreading the message ‘SAY NO TO FRAGILE BONES’ – our bones are priceless and deserve to be handled with care! WOD is the perfect time to boost #bonehealth awareness and understanding of the need for #osteoporosis prevention and management. The campaign will drive action in the fight against osteoporosis and fragility fractures by reaching out to the public, patients, caregivers, healthcare professionals and health authorities. You can participate too! Organize an informational event or lecture at your hospital or university, give press interviews, share social media, host a walk, or simply leverage the numerous posters and other resources on our website for your local campaigns. For ideas to kickstart your campaign planning, download our Posters and the Campaign Toolkit with examples for national societies, fracture liaison services, healthcare authorities and companies. #WorldOsteoporosisDay https://lnkd.in/dh6SCzX

🚀 Bonescreen joins TUM Venture Labs I Healthcare ✨ At TUM Venture Labs, the Bonescreen Team can integrate into a vibrant ecosystem of innovation, entrepreneurship, and cutting-edge research. Needless to say, we look forward to this collaboration! #Innovation #DeepTech #LifeSciences #TUMVentureLabs #BonescreenGmbH EIT Health Technical University of Munich

🤝🤖 Innovating Spine Surgery 🦴 👩💻 Bonescreen is partnering with LEM Surgical AG to advance the development of the next generation of spine surgical robots. As part of this collaboration, Bonescreen is contributing its expertise in machine learning to support LEM's cutting-edge technology. Both partners are committed to integrating the latest advancements in robotics, automation, and spine imaging to improve patient care. 🏥 👨⚕️

We warmly welcome the following new member companies to IOF’s Committee of Corporate Advisors (CCA): Angitia Biopharmaceuticals , IBEX Innovations , bonescreen and Anlene (Fonterra ). Thank you for joining us – your support makes a difference! We’d also like to take this opportunity to once again thank all our CCA members for their valued support, which is so essential to IOF’s missions encompassing advocacy, health professional education, public awareness, and patient care. Together we are working towards a shared vision of a world without fragility fractures! Curious about joining the IOF CCA and making an impact? Explore opportunities and connect with us by contacting isabelle.ragain@osteoporosis.foundation. Learn more about the IOF CCA Committee here: https://bit.ly/3delQ2F